Amyris makes progress on RNA COVID-19 vaccine platform
In California, Amyris announced highly promising preliminary data in a pre-clinical study of its ribonucleic acid (RNA) COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges. On October 22, 2020, Amyris announced that it entered into a collaboration agreement and exclusive license with the […]
